Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

XTNTXTNT
19 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in XTANT MED HLDGS INC

CITADEL ADVISORS LLC holds 191,369 shares of XTNT (XTANT MED HLDGS INC), worth $80,566 as of 2026-Q2. The position was increased (+18.9% shares).

Current Value

$80,566

Current Shares

191,369

Total Value Change

+$566

Total Shares Change

+124,313

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,369
+18.9%
$80,5660.0%$0.42
17
2026-Q1
Decreased
161,011
-44.0%
$89,8440.0%$0.59
0
2025-Q4
Increased
287,798
+259.4%
$225,6340.0%$0.77
25
2025-Q3
Increased
80,077
+20.0%
$51,9620.0%$0.64
17
2025-Q2
Decreased
66,708
-29.1%
$49,2970.0%$0.63
0
2025-Q1
New
94,115
-
$44,2340.0%$0.49
31
2024-Q4
Exited
0
-100.0%
$00.0%$0.46
0
2024-Q3
Increased
79,356
+5.2%
$53,6450.0%$0.67
15
2024-Q2
Increased
75,447
+15.3%
$47,5320.0%$0.63
16
2024-Q1
Increased
65,453
+9.3%
$76,5800.0%$1.17
16
2023-Q4
Increased
59,866
+88.5%
$67,6490.0%$1.13
22
2023-Q3
Increased
31,761
+17.2%
$34,9370.0%$1.10
16
2023-Q2
Increased
27,109
+20.5%
$25,2090.0%$0.92
16
2023-Q1
Decreased
22,503
-48.5%
$14,3460.0%$0.62
0
2022-Q4
New
43,658
-
$28,8140.0%$0.66
30
2021-Q3
Exited
0
-100.0%
$00.0%$1.10
0
2021-Q2
Decreased
36,531
-60.3%
$60,0000.0%$1.73
0
2021-Q1
Increased
91,973
+37.2%
$217,0000.0%$2.33
30
2020-Q4
New
67,056
-
$80,0000.0%$1.24
33

Other major holders of XTNT: RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used